Showing results (921-930 of 1,131) with videos related to

Sort By:
Pageof 114
International Journal of Radiation Biology|February 16, 2018
Characterization of a partial-body irradiation model with oral cavity shielding in nonhuman primatesMichael V Accardi, Oreola Donini, Adam Rumage, et al.
Journal of Biomedical Materials Research. Part A|March 26, 2016
Development and characterization of a naturally derived lung extracellular matrix hydrogelRobert A Pouliot, Patrick A Link, Nabil S Mikhaiel, et al.
Cancer Journal (Sudbury, Mass.)|May 28, 2013
Salvage-targeted kidney cancer therapy in patients progressing on high-dose interleukin-2 immunotherapy: the UCLA experienceFrédéric D Birkhäuser, Allan J Pantuck, Edward N Rampersaud, et al.
The Journal of Biological Chemistry|November 12, 2015
Identification of QS-21 as an Inflammasome-activating Molecular Component of Saponin AdjuvantsRobyn Marty-Roix, Gregory I Vladimer, Kimberly Pouliot, et al.
Cardiology|June 22, 2021
Use of the HAVOC Score to Identify Patients at Highest Risk of Developing Atrial FibrillationMitchell S V Elkind, Rolf Wachter, Atul Verma, et al.
CJC Open|March 29, 2021
Novel G1481V and Q1491H SCN5A Mutations Linked to Long QT Syndrome Destabilize the Nav1.5 Inactivation StateQuentin Plumereau, Olivier Theriault, Valérie Pouliot, et al.
Atmospheric Chemistry and Physics|June 23, 2025
Predicted impacts of heterogeneous chemical pathways on particulate sulfur over Fairbanks (Alaska), the Northern Hemisphere, and the Contiguous United StatesSara L Farrell, Havala O T Pye, Robert Gilliam, et al.
Scientific Reports|November 6, 2024
Multi-task Bayesian model combining FDG-PET/CT imaging and clinical data for interpretable high-grade prostate cancer prognosisMaxence Larose, Louis Archambault, Nawar Touma, et al.
PNAS Nexus|November 13, 2023
The sustainability of trade in wild plants-A data-integration approach tested on critically endangered Nardostachys jatamansiCarsten Smith-Hall, Dipesh Pyakurel, Henrik Meilby, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2009
Phase II multicenter trial of anthracycline rechallenge with pegylated liposomal doxorubicin plus cyclophosphamide for first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclinesMaureen E Trudeau, Mark J Clemons, Louise Provencher, et al.
Pageof 114